Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Seraxis Inc. closed a Series B financing round and enters into a collaboration agreement with Medytox Inc. Read more →
- BioLife Solutions Executes 10 Year Supply Agreement with Bellicum Pharmaceuticals for CryoStor® Use in Cellular Immunotherapies Read more →
- Pluristem’s Phase III Critical Limb Ischemia Study Wins $8 Million Grant from Europe’s Horizon 2020 Program Read more →